Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Antilymphocyte Serum × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Acute 2 Hematologic Neoplasms 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Shwachman-Diamond Syndrome 1 Recurrence 1 Rasmussen subacute encephalitis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Lymphoma, Non-Hodgkin 1 Leukemia, Biphenotypic, Acute 1 Lambert-Eaton Myasthenic Syndrome 1 Hemoglobinuria, Paroxysmal 1 Congenital amegakaryocytic thrombocytopenia 1 Bone Marrow Failure Disorders 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1 Anemia, Hypochromic 1 Anemia, Diamond-Blackfan 1

Interventions

pembrolizumab 27 Nivolumab 26 cabozantinib 25 Magnetic Resonance Spectroscopy 19 Specimen Handling 16 Ipilimumab 16 lenvatinib 10 belzutifan 7 atezolizumab 7 Biopsy 7 Axitinib 7 Sunitinib 6 Everolimus 6 CTLA-4 Antigen 6 avelumab 5 aldesleukin 5 Radiosurgery 5 Immunoglobulin G 5 Bevacizumab 5 pazopanib 4 fludarabine 4 Disulfides 4 Cyclophosphamide 4 zimberelimab 3 palbociclib 3 cemiplimab 3 Radiotherapy 3 Nephrectomy 3 IFL protocol 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡